Search Within

David Chung

Formats
  1. Meeting Abstract (177)
  2. Journal Article (63)
  3. Research Letter (4)
  4. Correspondence (2)
  5. Book Section (1)
  6. Review (1)
Groups
  1. Bone Marrow Transplant (248)
  2. Center for Hematologic Malignancies (248)
  3. Department of Medicine (248)
  4. Hematologic Malignancies, Division of (248)
  5. Survivorship Research (220)
  6. Myeloma (189)

More Groups

People
  1. Sergio Giralt (207)
  2. Heather Landau (206)
  3. Alexander Lesokhin (174)
  4. Hani Hassoun (165)
  5. Gunjan Shah (155)
  6. Neha Korde (139)

More People

Years
  1. 2025 (3)
  2. 2024 (40)
  3. 2023 (40)
  4. 2022 (34)
  5. 2021 (15)
  6. 2020 (18)

More Years

Publications
  1. Blood (98)
  2. Clinical Lymphoma, Myeloma and Leukemia (44)
  3. Biology of Blood and Marrow Transplantation (28)
  4. Leukemia and Lymphoma (9)
  5. Journal of Clinical Oncology (8)
  6. Transplantation and Cellular Therapy (7)

More Publications

Publishers
  1. American Society of Hematology (103)
  2. Elsevier Inc. (82)
  3. Nature Publishing Group (13)
  4. American Association for Cancer Research (9)
  5. Taylor & Francis Group (9)
  6. American Society of Clinical Oncology (8)

More Publishers

Results (248)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
    Journal Article

    Einarsdottir, S.; Lobaugh, S.; Luan, D.; Gomez-Llobell, M.; Subramanian, P.; Devlin, S.; Chung, D.; Dahi, P. B.; Falchi, L.; Giralt, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker in multiple myeloma
    Journal Article

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C. R.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rajeeve, S.; Costa, B. A.; Jurgens, E. M.; Nishimura, N.; Farzana, T.; Firestone, R. S.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial
    Meeting Abstract

    Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Uncovering the tumor antigen landscape in patients undergoing dendritic cell/myeloma fusion vaccine with lenalidomide maintenance treatment
    Meeting Abstract

    Karagkouni, D.; Cheloni, G.; Nanda, S.; Ma, Y. L.; Wang, S. S.; Katopodi, L. X.; Saldarriaga, I.; Pita-Juarez, Y.; Chung, D. J.; Shah, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Initial results from the ASH research collaborative's COVID-19 outcomes in myeloma and the impact of vaccines (COSMIC): A decentralized, real-world evidence study for patients with multiple myeloma to monitor outcomes related to COVID-19 vaccines and infections
    Meeting Abstract

    Usmani, S. Z.; Semmel, E. A.; James, S.; Wood, W. A.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; Zonder, J. A.; Rubinstein, S. M.; D'Souza, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Immune-MRD status informs tumor-MRD outcome prognostication in multiple myeloma patients on lenalidomide maintenance
    Meeting Abstract

    Firestone, R. S.; Simhal, A. K.; McAvoy, D.; Jurgens, E. M.; GarceĢs, J. J.; Nemirovsky, D.; Derkach, A.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A high-fiber dietary intervention (NUTRIVENTION) in precursor plasma cell disorders improves biomarkers of disease and may delay progression to myeloma
    Meeting Abstract

    Shah, U. A.; Cogrossi, L. L.; Derkach, A.; Castro, F.; Fei, T.; DeWolf, S.; Garces, J. J.; Policastro, A.; Grioni, M.; Sisti, S.; more...
    Blood (2024)

    Fulltext@MSK | Save